Overview

Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
To investigate safety and pharmacokinetics of mitiglinide and metformin in a fixed-dose combination of mitiglinide/metformin, compared with free combination of mitiglinide and metformin in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
JW Pharmaceutical
Treatments:
Metformin
Mitiglinide